Clostridium Difficile

Infectious diseases specialists vital in LTC facilities

Infectious diseases specialists vital in LTC facilities

Coping with the complicated management of infectious diseases is among the many challenges facing long-term care facilities today. Residents with multiple comorbidities often are prescribed broad-spectrum antibiotics and it seems as though methicillin-resistant Staphylococcus aureus (MRSA) and other (increasingly) drug-resistant bugs are everywhere. Outbreaks are common, ranging from norovirus and influenza to Clostridium difficile and scabies.

PDI announces new pail

PDI announces new pail

PDI's new Sani-Cloth® Pail and Refill format for Sani-Cloth® Bleach and Sani-Cloth® AF3 Germicidal Disposable Wipes is designed to meet needs of environmental services, the company announced.

C. diff vaccine moves closer to reality with launch of large Phase III trial

C. diff vaccine moves closer to reality with launch of large Phase III trial

By

A potential Clostridium difficile vaccine performed well in initial tests and now has moved into a large Phase III trial, researchers announced today. The news from developer Sanofi Pasteur raises hopes that the antibiotic-resistant infection can be prevented in long-term care facilities and other settings where it has become a deadly scourge.

Frozen fecal transplants cure C. diff, could be a game-changer, researchers say

By

Fecal transplants to cure Clostridium difficile could become more common, following a trial that successfully used frozen stool specimens, according to researchers at Massachusetts General Hospital.

Acute, post-acute partnerships reduce C. diff about 50% in Washington state

By

Hospitals and post-acute facilities in Washington state have cut their rate of Clostridium difficile infections in half since 2012 by partnering with each other in a robust infection control program, according to local news reports.

Hand hygiene prior to donning gloves is unnecessary, study finds

By

Performing hand hygiene prior to putting on gloves may not be a necessary practice, suggests recently published research in the American Journal of Infection Control.

Nursing assistants most vulnerable to C. diff contamination on hands, research shows

By

Healthcare workers frequently have Clostridium difficile spores on their hands after providing routine care for an infected person, and nursing assistants have by far the highest incidence of contamination, according to recently published research from France.

Heavily soiled healthcare linens not 'regulated waste,' OSHA confirms

Heavily soiled healthcare linens not 'regulated waste,' OSHA confirms

By

Long-term care facilities and other healthcare providers are not required to dispose of contaminated linen as "regulated waste," the Occupational Safety and Health Administration clarified in a recent letter.

C. diff sources 'diverse': study

C. diff sources 'diverse': study

By

New research challenges assumptions about how Clostridium difficile is transmitted.

Fecal matter pills cure C. diff, physician says

By

Pills created from fecal matter are the latest breakthrough in treating Clostridium difficile, according to a doctor in Canada who says he has cured about 30 people this way.

C. diff results stay the same

By

High and low dosages of a popular antibiotic are equally good at combating Clostridium difficile infections, according to a new study.

Sanofi moves to new stage in C. diff  vaccine program

Sanofi moves to new stage in C. diff vaccine program

By

Sanofi Pasteur's vaccine division has started a Phase III clinical trial to evaluate the safety and efficacy of a vaccine for Clostridium difficile.

Study challenges basic assumptions about C. diff transmission

By

A new study contradicts widely held assumptions about how Clostridium difficile infection occurs, which may lead long-term care providers to step up control measures.

Proton-pump inhibitors increase risk of nosocomial C. diff infection: study

By

People who take proton-pump inhibitor medications are at increased risk for developing a Clostridium difficile infection, according to a recently published study that supports previous findings.

Antibiotic resistance leads to 23,000 deaths a year, providers must implement best practices: CDC 'landmark' report

Antibiotic resistance leads to 23,000 deaths a year, providers must implement best practices: CDC 'landmark' report

By

Nursing homes are on the front lines in the increasingly urgent battle against antibiotic-resistant infections, according to a comprehensive new report that ranks the most dangerous antibiotic-resistant microorganisms. The report identifies four core actions to fight the spread of antibiotic resistance.

Dosage amounts create similar improvement in C. diff cases

By

High and low dosages of a popular antibiotic offer little difference in the outcomes of Clostridium difficile infections, according to a new study.

Toxin identified to diagnose fatal Clostridium difficile cases

By

The bacterial infection Clostridium difficile is most effectively diagnosed through a method called cytotoxin assay, a new study has found.

C. diff therapy put in doubt

C. diff therapy put in doubt

By

Probiotics are not effective in preventing diarrhea associated with Clostridium difficile, according to a large study that calls into question previous findings.

C. diff spotlight: Vaccine trial and caregiver checklist

C. diff spotlight: Vaccine trial and caregiver checklist

By

Back in June, I declared medication to be the long-term care topic of the summer. But this week, a different topic has stolen the spotlight: Clostridium difficile.

Powerful duo fights C. diff

Powerful duo fights C. diff

By

Antibiotics often aren't enough to combat Clostridium difficile. But when combined with probiotics, or "good" bacteria, the results are striking. The treatment combo lessens the likelihood of C. diff symptoms by 64%, according to a recent study.

FDA responds to provider pressure, backs off stricter control of fecal transplants for C. diff

By

Individuals with treatment-resistant Clostridium difficile can undergo fecal transplants after giving informed consent, the Food and Drug Administration recently announced. This is a victory for providers, who pushed back after the FDA recently announced it would tighten regulations around the transplants.

FDA wants to fast-track treatments for C. diff

By

Clostridium difficile poses a serious public health threat and potential treatments should be fast-tracked, the Food and Drug Administration stated in a newly proposed regulation.

Probiotics reduce risk of C. diff symptoms by 64%, researchers say

By

Long-term care facilities dealing with an outbreak of Clostridium difficile have a good chance of reducing symptoms of the infection by administering probiotics, according to a recently released comprehensive review of randomized trials.

Depression tied to C. diff

Depression tied to C. diff

By

Depressed or lonely people are at increased risk of Clostridium difficile infection, according to research in BMC Medicine.

Catching bad bugs

Catching bad bugs

By

New strains of drug-resistant pathogens are targets of more scrutiny among infection control professionals employed in long-term care environments.

Fecal transplants to treat C. diff now need FDA approval

By

The Food and Drug Administration is moving to tighten regulations around fecal transplants, which research has shown to be an effective treatment for Clostridium difficile infection.

Depressed, lonely seniors are more likely to get C. diff, researchers find

By

People who are depressed or lonely are at increased risk of Clostridium difficile infection, according to recently published research.

Three risk factors could help uncover C. diff. carriers, researchers say

By

Long-term care providers might want to pay special attention to residents with certain recently identified risk factors for Clostridium difficile. These factors are chronic dialysis, recent hospitalization and use of corticosteroids such as prednisone.

CompanyBriefs

Pfizer must pay $142 million for the marketing and prescribing of epilepsy drug Neurontin for unapproved uses, a federal appeals court has ruled. The justices refused to overturn a jury's previous verdict. The jury determined Pfizer marketed Neurontin for bipolar disorder, migraines and neuropathic pain. The Food and Drug Administration had not approved the medicine for any of those uses.

Stomach acid drugs raise risk of C. diff

By

Stomach acid is often treated with medications such as Pepcid, but that could put long-term care residents or hospitalized patients at risk for Clostridium difficile, according to a new analysis.

Don't miss any McKnight's news